Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
Hoosier Cancer Research Network
Hoosier Cancer Research Network
Barbara Ann Karmanos Cancer Institute
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
National Cheng-Kung University Hospital
National OncoVenture